On ECHEMI
Home > Drugs > Hainan Lingkang Pharmaceutical Co., Ltd.
Hainan Lingkang Pharmaceutical Co., Ltd.
  • Founded in:

    2013-04-22
  • Country:

    China China
  • Address:

    No. 16, Yaogu Erheng Road, Yaogu Industrial Park, Haikou National High-tech Industrial Development Zone, Hainan Province
  • Tax NO.:

    91460000062331438Q
  • Registered Funds:

    200 million yuan
  • Website:

  • Email:

Related Drugs
Water-soluble vitamins for injection
The main ingredients of this product are multivitamins, and the components in each 1000 bottles are:
Name Description Content CAS NO. Registered Holders
Various vitamins

This product is a part of intravenous nutrition, used to supplement the daily physiological needs of various water-soluble vitamins so that the body's relevant biochemical reactions can proceed normally.

More

This product is a part of intravenous nutrition, used to supplement the daily physiological needs of various water-soluble vitamins so that the body's relevant biochemical reactions can proceed normally.

0
Disodium clodronate
Name Description Content CAS NO. Registered Holders
CLODRONIC ACID

Extract from the above information

More

Extract from the above information

10596-23-3 3
Diisopropylamine dichloroacetate
Name Description Content CAS NO. Registered Holders
Diisopropylammonium dichloroacetate

660-27-5 14
Naloxone Hydrochloride for Injection
Main ingredients: Naloxone hydrochloride, auxiliary materials are mannitol, sodium dihydrogen phosphate, disodium hydrogen phosphate. Chemical name: 17-allyl-4,5a-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride dihydrate. Chemical structure: Molecular formula: C19H21NO4·HCl·2H2O Molecular weight: 399.87
Name Description Content CAS NO. Registered Holders
Naloxone hydrochloride

This product is an opioid receptor antagonist, which has almost no pharmacological activity itself, but can competitively antagonize various opioid receptors and has a strong affinity for m receptors. It can completely or partially correct the central inhibitory effects of opioid substances, such as respiratory depression, sedation and hypotension; it has a wake-up effect on animals with acute ethanol poisoning; it is a pure opioid receptor antagonist and does not cause respiratory depression, psychotomimetic reactions or miotic reactions; there is no drug resistance, nor physiological or mental dependence.

More

This product is an opioid receptor antagonist, which has almost no pharmacological activity itself, but can competitively antagonize various opioid receptors and has a strong affinity for m receptors. It can completely or partially correct the central inhibitory effects of opioid substances, such as respiratory depression, sedation and hypotension; it has a wake-up effect on animals with acute ethanol poisoning; it is a pure opioid receptor antagonist and does not cause respiratory depression, psychotomimetic reactions or miotic reactions; there is no drug resistance, nor physiological or mental dependence.

357-08-4 32
Nicergoline for injection
Nicergoline
Name Description Content CAS NO. Registered Holders
Nicergoline

This product is a semi-synthetic ergot alkaloid derivative. It has α receptor blocking and vasodilation effects. It can enhance the metabolism of brain cell energy and increase the utilization of oxygen and glucose. It can promote the conversion of neurotransmitter dopamine to enhance nerve conduction, strengthen brain protein biosynthesis, and improve brain function. Toxicity tests failed to show that nicergoline has teratogenic effects.

More

This product is a semi-synthetic ergot alkaloid derivative. It has α receptor blocking and vasodilation effects. It can enhance the metabolism of brain cell energy and increase the utilization of oxygen and glucose. It can promote the conversion of neurotransmitter dopamine to enhance nerve conduction, strengthen brain protein biosynthesis, and improve brain function. Toxicity tests failed to show that nicergoline has teratogenic effects.

27848-84-6 35
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.